Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma

		Phase:		Phase 2

		Treatment ID#:		716

		Age Group:		Adults Only

		Min Karnofsky Score:		50: Requires considerable assistance and frequent medical care

		Conditions:		Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Allowed First relapse of NHL in the CNS, No prior radiotherapy to the CNS, No prior bone marrow transplantation

		Last Updated:		05/01/2007

		Tumor Types:		Lymphomas Metastatic Brain Tumor


		Comments:		Treatment includes high-dose methotrexate given IV and intra-arterial chemotherapy with carboplatine given inconjunction with blood-brain barrier disruption. After 4 cycles patients in complete response undergo high dose chemotherapy with autologous peripheral stem cell transplantation. No radiotherapy id given to responding patients.

		Treatment Type:		Chemotherapy

		Contact:		Dr.Edward Neuwelt M.D. Professor Oregon Health Sciences University 3181 SW Sam Jackson Park Rd L603 Portland, OR 97239 USA Phone: (503)494-5626 Fax: (503)494-5627 E-mail: neuwelte@ohsu.edu Website: www.ohsu.edu/bbb

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By